Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Cancer Treatment and Research
|
March 5, 2003
TGF-beta signaling alterations in cancer
Yansong Bian, Virginia Kaklamani, Jennifer Reich, et al.
Cancer Letters
|
January 24, 2013
MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma
Lu Zhang, Zhi-Jun Sun, Yansong Bian, et al.
Plos One
|
October 15, 2013
Inhibition of mTOR reduces anal carcinogenesis in transgenic mouse model
Zhi-Jun Sun, Lu Zhang, Wei Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2012
Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model
Zhi-Jun Sun, Lu Zhang, Bradford Hall, et al.
Cancer Biology & Therapy
|
November 16, 2006
Detecting low-abundance p16 and p53 mutations in pancreatic juice using a novel assay: heteroduplex analysis of limiting dilution PCRs
Yansong Bian, Hiroyuki Matsubayashi, Chung-Pin Li, et al.
Neoplasia (New York, N.Y.)
|
November 8, 2014
CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer
Hai Lu, Carol Yan, Xin Xin Quan, et al.
International Journal of Biological Sciences
|
March 24, 2015
MEK inhibitor PD-0325901 overcomes resistance to CK2 inhibitor CX-4945 and exhibits anti-tumor activity in head and neck cancer
Yansong Bian, Jiawei Han, Vishnu Kannabiran, et al.
Human Molecular Genetics
|
September 25, 2007
Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development
Yansong Bian, Thomas J Knobloch, Maureen Sadim, et al.
Journal of Translational Medicine
|
February 21, 2013
Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling
Bradford Hall, Hideyuki Nakashima, Zhi-Jun Sun, et al.
The Journal of Pathology
|
November 22, 2013
Epidermal overexpression of transgenic ΔNp63 promotes type 2 immune and myeloid inflammatory responses and hyperplasia via NF-κB activation
Jihui Du, Rose-Anne Romano, Han Si, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Cancer Treatment and Research
|
March 5, 2003
TGF-beta signaling alterations in cancer
Yansong Bian, Virginia Kaklamani, Jennifer Reich, et al.
Cancer Letters
|
January 24, 2013
MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma
Lu Zhang, Zhi-Jun Sun, Yansong Bian, et al.
Plos One
|
October 15, 2013
Inhibition of mTOR reduces anal carcinogenesis in transgenic mouse model
Zhi-Jun Sun, Lu Zhang, Wei Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2012
Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model
Zhi-Jun Sun, Lu Zhang, Bradford Hall, et al.
Cancer Biology & Therapy
|
November 16, 2006
Detecting low-abundance p16 and p53 mutations in pancreatic juice using a novel assay: heteroduplex analysis of limiting dilution PCRs
Yansong Bian, Hiroyuki Matsubayashi, Chung-Pin Li, et al.
Neoplasia (New York, N.Y.)
|
November 8, 2014
CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer
Hai Lu, Carol Yan, Xin Xin Quan, et al.
International Journal of Biological Sciences
|
March 24, 2015
MEK inhibitor PD-0325901 overcomes resistance to CK2 inhibitor CX-4945 and exhibits anti-tumor activity in head and neck cancer
Yansong Bian, Jiawei Han, Vishnu Kannabiran, et al.
Human Molecular Genetics
|
September 25, 2007
Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development
Yansong Bian, Thomas J Knobloch, Maureen Sadim, et al.
Journal of Translational Medicine
|
February 21, 2013
Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling
Bradford Hall, Hideyuki Nakashima, Zhi-Jun Sun, et al.
The Journal of Pathology
|
November 22, 2013
Epidermal overexpression of transgenic ΔNp63 promotes type 2 immune and myeloid inflammatory responses and hyperplasia via NF-κB activation
Jihui Du, Rose-Anne Romano, Han Si, et al.
Page
of 3